Pediatrics, Nephrology

• 

  People

  • Administrative Positions

    • Nagaraj, Shashi Kumar, Chief, Division of Pediatric Nephrology

  • Professorships

    • Gbadegesin, Rasheed Adebayo, Wilburt C. Davison Distinguished Professor

  • Primary Appointments

    • Chambers, Eileen Tsai, Associate Professor of Pediatrics
    • Chua, Annabelle Nancy, Associate Professor of Pediatrics
    • Foreman, John William, Consulting Professor in the Department of Pediatrics
    • Gbadegesin, Rasheed Adebayo, Professor of Pediatrics
    • Kumar, Reeti, Assistant Professor of Pediatrics
    • Nagaraj, Shashi Kumar, Professor of Pediatrics
    • Sheldon, Candice Ray, Assistant Professor of Pediatrics
    • Wigfall, Delbert Raye, Professor of Pediatrics
• 

  Administers Grant

  • A New Locus for Hereditary FSGS on Chromosome 2p
  • A PHASE 2, OPEN-LABEL, SINGLE-ARM, COHORT STUDY TO EVALUATE THE SAFETY, EFFICACY, AND PHARMACOKINETICS OF SPARSENTAN TREATMENT IN PEDIATRIC SUBJECTS WITH SELECTED PROTEINURIC GLOMERULAR DISEASES (EPPIK)
  • A PHASE 2/3 TRIAL OF THE EFFICACY AND SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME
  • A PHASE 3, OPEN-LABEL, MULTICENTER STUDY OF ALXN1210 IN CHILDREN AND ADOLESCENTS WITH ATYPICAL HEMOLYTIC-UREMIC SYNDROME (aHUS)
  • A Phase II Randomized, Placebo-Controlled, Double-Blind, Parallel Arms with Switchover, Pilot Study to Evlaluate the Efficacy and Safety of Intravenous Abatracept in Treamtne Resistant Nephrotic Syndrom (Focal Sebmental Glomerulosclerosis/Minimal Cha
  • A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PARALLEL, ACTIVE-CONTROL STUDY OF THE EFFECTS OF SPARSENTAN, A DUAL ENDOTHELIN RECEPTOR AND ANGIOTENSIN RECEPTOR BLOCKER, ON RENAL OUTCOMES IN PATIENTS WITH PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
  • A study to test BI 764198 in people with a type of kidney disease called focal segmental glomerulosclerosis.
  • ACTH for Frequently Relapsing and Steroid Dependent Nephrotic Syndrome in Children
  • Acoustic Device to Prevent Antibody Mediated Organ Transplant Failure
  • Advancing Transplantation Outcomes in Children - Mechnistic
  • An Extended Access Program to Assess Long Term Safety of Bardoxolone Methyl in Patients with Chronic Kidney Disease
  • An Observational, Multi-Center, Multi-National Long Term Follow-up Study of Atypical Hemolytic Uremic Syndrome (AHUS) Patients Treated with Eculizumab in a Prior Clinical Study
  • An Open-Label, Randomized, Parallel Group Study to Assess the Safety and Efficacy of Hectorol® (doxercalciferol capsules) in Pediatric Patients with Chronic Kidney Disease Stages 3 and 4 with Secondary Hyperparathyroidism Not Yet on Dialysis
  • An observational, non-interventional, multi-center, multi-national study of patients with Atypical Hemolytic-Uremic Syndrome (aHUS Registry)
  • Defining the Landscape of HLA Risk Alleles in Primary Nephrotic Syndrome and Post Kidney Transplant Recurrence
  • Defining the role of chloride channel 5 in maintaining podocyte structure and functions
  • Functional and Phenotypic Characterization of a New FSGS Gene
  • GENETIC BASIS OF CORTICOSTEROID RESPONSE IN CHILDHOOD NEPHROTIC SYNDROME
  • Genetics of childhood nephrotic syndrome
  • H3 AFRICA KIDNEY DISEASE COHORT STUDY
  • H3 Africa Kidney Disease Research Network
  • H3Africa Kidney Disease Research Network
  • IDENTIFICATION OF VUR GENES BY COMBINED LINKAGE ANALYSIS AND EXOME SEQUENCING
  • Identification of New Non-invasive Diagnostic Tools for Vesicoureteric Reflux (VUR)
  • Integrative Proteomics & Metabolomics for Pediatric Glomerula Disease Biomarkers
  • Integrative genomics of glomerular disease in the CureGN cohort
  • Nephrotic Syndrome Rare Disease Clinical Research Network III (NEPTUNE III) ("Study")
  • Novel development ofan acoustofluidic device for targeted antibody removal in pediatric organ transplan rejection
  • Pharmacokinetics of Cefepime in Children Receiving Continuous Renal Replacement Therapy
  • Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant
  • Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant
  • Single arm Study of ALXN1210 in Complement Inhibitor Treatment-Naive Adult and Adolescent Patients with Atypical Hemolytic Uremic Syndrome (aHUS)
  • Vifor PA21 Phaslyra
  • Wake Forest Collaborative Application for an APOLLO Clinical Center

Add data to my Website